Web Results

Johnson & Johnson - Wikipedia


Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industri...

J&J Wins U.S. Approval for First-in-Class Diabetes Drug - Bloomberg


Mar 29, 2013 ... J&J Wins U.S. Approval for First-in-Class Diabetes Drug. Anna Edney ... “I worry its use in women will be somewhat minimal,” Butler said.

FDA approves Johnson & Johnson diabetes drug, canagliflozin ...


Mar 29, 2013 ... FDA has approved a new diabetes drug from Johnson & Johnson, making it the first in its class to be approved in the United States. ... of biologic drugs must wait six months after winning federal approval to begin selling them.

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the ...


Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 competitors ... Since Invokana helped lift Johnson's first-quarter sales in the U.S. last quarter, let's look at its ... Express Scripts expects spending on diabetes treatment will grow 11% in ... the first in a new class of diabetes drugs to win FDA ap...

J&J faces big spending, big rivals for new diabetes drug Invokana ...


Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to ... And it's true that diabetes patients often have to change meds to keep control of ... J&J wins first FDA approval for new class of diabetes drug

FDA Approves Johnson Johnsons New Diabetes Drug


Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of ... Janssen will partner with other Johnson & Johnson companies focused on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.

UPDATED: J&J wins first FDA approval for new class of diabetes drug


Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ... UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a relatively high rate of genital infections which will limit uptake in our ...

Invokana: J&J advances a trailblazer in diabetes | FierceBiotech


On its approval, analysts expected peak sales of around $650 million for Invokana, but competitors ... a diabetes drug, and the heads of its Janssen unit hope Invokana's success will ... J&J wins first FDA approval for new class of diabetes drug

FDA Approves First in New Class of Diabetes Drugs - Invokana


Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ... As the first company to win FDA approval, Johnson & Johnson has a leg up on industry rivals developing their own ... More details on the studies will be presented at the American Diabetes Association annual meeting in June.

Invokana - Uses, Side Effects and Dangerous Medical ... - Drug Center


Oct 14, 2016 ... Most type 2 diabetes drugs manipulate insulin levels, which could lead to complications ... Johnson & Johnson, the manufacturer of Invokana, received approval for the drug from the FDA in 2013. ... How does Invokana work? ... It's important to keep track of your blood sugar levels and know the symptoms of ....